Pancreatic Surgery Practice Questions

Q: Which type of pancreatitis generally has a good prognosis?

Gallstone pancreatitis. **Explanation:** The prognosis of acute pancreatitis is largely determined by the etiology and the ability to remove the inciting factor. **Why Gallstone Pancreatitis is the correct answer:** Gallstone pancreatitis generally has a **better prognosis** because it is often a self-limiting event. Once the offending gallstone passes into the duodenum or is removed via ERCP, the inflammatory process typically resolves rapidly. Furthermore, definitive treatment (cholecystectomy) can be performed during the same admission to prevent recurrence, leading to lower long-term morbidity compared to other types. **Analysis of Incorrect Options:** * **Postoperative Pancreatitis:** This carries a **poor prognosis** and high mortality rate. It often occurs after major abdominal or cardiac surgeries and is frequently associated with multi-organ dysfunction and delayed diagnosis. * **Alcoholic Pancreatitis:** While common, it often involves recurrent episodes of acute inflammation. It has a higher tendency to progress to chronic pancreatitis and is associated with poorer patient compliance and nutritional deficiencies. * **Chronic Pancreatitis:** This is a progressive, irreversible inflammatory disease. It is not an "acute" event with a prognosis of recovery; rather, it leads to permanent endocrine and exocrine insufficiency and carries a risk of pancreatic malignancy. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause of Acute Pancreatitis:** Gallstones (followed by Alcohol). * **Ranson’s Criteria:** Used to predict severity; a score of <3 indicates a good prognosis (mortality <1%). * **Best initial test:** Serum Amylase/Lipase (Lipase is more specific). * **Gold Standard for diagnosis/severity:** Contrast-Enhanced CT (CECT) scan (best done after 72 hours). * **Management:** Early aggressive fluid resuscitation is the cornerstone of treatment.

Q: What is the most common oncogene involved in pancreatic carcinoma?

K-RAS. **Explanation:** **K-RAS** is the most common genetic alteration in pancreatic adenocarcinoma, found in over **90-95%** of cases. It is a **proto-oncogene** located on chromosome 12p. Mutations in K-RAS lead to a constitutively active RAS protein, which triggers continuous downstream signaling for cell proliferation and survival. In the progression of pancreatic cancer (PanIN - Pancreatic Intraepithelial Neoplasia), K-RAS mutation is typically an **early event**. **Analysis of Incorrect Options:** * **P53 (Option A):** This is a **tumor suppressor gene** (not an oncogene). While it is the most commonly mutated gene in human cancers overall and is mutated in about 50-75% of pancreatic cancers, it is usually a **late event** in the progression of the disease. * **APC (Option C):** The Adenomatous Polyposis Coli gene is primarily associated with **Familial Adenomatous Polyposis (FAP)** and colorectal cancer. It is not a hallmark of pancreatic adenocarcinoma. * **DCC (Option D):** "Deleted in Colorectal Carcinoma" is a tumor suppressor gene associated with colon cancer progression. It does not play a primary role in pancreatic oncogenesis. **High-Yield Clinical Pearls for NEET-PG:** * **Most common Tumor Suppressor Gene** in pancreatic cancer: **CDKN2A (p16)** (mutated in ~95% of cases). * **SMAD4 (DPC4):** Mutation is highly specific for pancreatic cancer and often indicates a poor prognosis/metastatic disease. * **Risk Factors:** Smoking (strongest environmental factor), Chronic pancreatitis, and Diabetes Mellitus. * **Tumor Marker:** **CA 19-9** (used for monitoring response to treatment, not for screening).

Q: What is the most common complication after ERCP?

Acute pancreatitis. **Explanation:** **Post-ERCP Pancreatitis (PEP)** is the most common complication following Endoscopic Retrograde Cholangiopancreatography, occurring in approximately **3% to 10%** of unselected cases. The underlying mechanism involves mechanical trauma to the papilla, hydrostatic injury from contrast injection into the pancreatic duct, or thermal injury from sphincterotomy. This leads to premature activation of pancreatic enzymes and subsequent autodigestion of the gland. **Analysis of Options:** * **A. Acute Pancreatitis (Correct):** It remains the leading complication. Risk factors include female gender, young age, sphincter of Oddi dysfunction, and difficult cannulation. * **B. Acute Cholangitis:** While it can occur due to introduced infection or incomplete biliary drainage, it is less common than pancreatitis (approx. 1%). * **C. Acute Cholecystitis:** This is a rare complication, usually occurring when contrast is injected into a gallbladder with pre-existing stones or cystic duct obstruction. * **D. Duodenal Perforation:** This is a serious but rare complication (approx. 0.5%), typically occurring during sphincterotomy (peri-ampullary) or due to endoscope trauma. **High-Yield Pearls for NEET-PG:** * **Prevention:** Prophylactic **Rectal Indomethacin** (NSAIDs) and placement of a temporary **Pancreatic Duct (PD) Stent** are the most effective strategies to reduce the risk of PEP. * **Diagnosis:** PEP is defined as new-onset upper abdominal pain with serum amylase/lipase levels ≥3 times the upper limit of normal, 24 hours after the procedure. * **Second most common complication:** Hemorrhage (post-sphincterotomy bleeding).

Q: Which of the following is not a complication of a pseudopancreatic cyst?

Malignancy. A **pseudopancreatic cyst** is a localized collection of fluid, pancreatic enzymes, and debris surrounded by a wall of fibrous or granulation tissue. Unlike true cysts, it lacks an epithelial lining. ### Why Malignancy is the Correct Answer The defining characteristic of a pseudocyst is the **absence of an epithelial lining**. Since there is no epithelium, there is no cellular substrate for neoplastic transformation. Therefore, a pseudocyst **never** undergoes malignant change. If a cystic lesion of the pancreas shows malignancy, it was likely a cystic neoplasm (like Mucinous Cystadenoma) from the outset, which can often be misdiagnosed as a pseudocyst. ### Explanation of Other Options (Complications) * **Infection:** This is a common complication where the cyst becomes an abscess, presenting with fever, leukocytosis, and worsening pain. * **Hemorrhage:** This occurs due to the erosion of the cyst into adjacent major vessels (most commonly the **Splenic Artery**), leading to a pseudoaneurysm or bleeding into the cyst cavity. * **Rupture:** The cyst can rupture into the peritoneal cavity (causing pancreatic ascites/peritonitis) or into hollow viscera like the stomach or duodenum. ### High-Yield Clinical Pearls for NEET-PG * **Timing:** Pseudocysts typically form **4–6 weeks** after an episode of acute pancreatitis. * **Most Common Site:** The **Lesser Sac**. * **Management:** Most (up to 50%) resolve spontaneously. Intervention (e.g., Cystogastrostomy) is indicated if the cyst is symptomatic, enlarging, or complicated. * **Gold Standard Diagnosis:** Contrast-Enhanced CT (CECT). * **Biochemical Marker:** High amylase levels in the cyst fluid help differentiate it from other cystic lesions.

Q: What is the best method for localizing an insulinoma?

Endoscopic ultrasonography with intra-operative palpation. **Explanation:** Insulinomas are the most common functional neuroendocrine tumors of the pancreas. They are typically small (<2 cm), solitary, and benign. Because of their small size, localization is the primary challenge in surgical management. **Why Option A is Correct:** The "gold standard" for localizing an insulinoma is a combination of **Endoscopic Ultrasonography (EUS)** pre-operatively and **Intra-operative Ultrasound (IOUS) with manual palpation** during surgery. * **EUS** has a high sensitivity (70–95%) for detecting small lesions in the head and body of the pancreas. * **Intra-operative palpation combined with IOUS** is the most definitive method, reaching a sensitivity of nearly 100%. Surgeons rely on the firm consistency of the tumor compared to the softer pancreatic tissue. **Analysis of Incorrect Options:** * **B & D (MRI and CECT):** While CECT (triple-phase) is often the first-line screening tool, its sensitivity for tumors <1 cm is relatively low (approx. 60%). MRI is slightly better but still inferior to EUS and IOUS. * **C (Selective retroperitoneal sonoendoscopy):** This is not a standard clinical term or procedure used for insulinoma localization. **High-Yield Clinical Pearls for NEET-PG:** 1. **Whipple’s Triad:** Symptoms of hypoglycemia during fasting, documented low blood glucose ( 3 μU/mL), elevated C-peptide (>0.6 ng/mL), and absence of sulfonylureas in urine. 3. **Medical Management:** Diazoxide is the drug of choice to inhibit insulin release before surgery. 4. **Surgical Management:** Enucleation is preferred for superficial tumors; distal pancreatectomy or Whipple’s procedure is reserved for deep-seated or large tumors.

Q: Which of the following is NOT a criterion for severity in acute pancreatitis?

Serum lipase elevated 3-fold. **Explanation:** The diagnosis of acute pancreatitis requires at least two of the following three criteria: (1) characteristic abdominal pain, (2) serum amylase or lipase levels ≥3 times the upper limit of normal, and (3) characteristic findings on contrast-enhanced CT. While a **3-fold elevation of serum lipase** is essential for **diagnosis**, it has **no correlation with the severity** or prognosis of the disease. A patient can have lipase levels ten times the normal limit and still have mild, self-limiting disease. In contrast, the severity of acute pancreatitis is determined by the presence of organ failure and local/systemic complications (as per the **Revised Atlanta Classification**). Organ failure is defined using the **Modified Marshall Scoring System**, which assesses three organ systems: * **Respiratory (Option C):** A PaO2/FiO2 ratio ≤ 300 (or PaO2 1.9 mg/dL (often rounded to > 2.0 mg/dL) indicates renal failure. * **Cardiovascular (Option D):** Systolic blood pressure 150 mg/L at 48 hours. * **Best imaging for severity:** Contrast-Enhanced CT (CECT), ideally performed 72–96 hours after symptom onset to accurately assess necrosis. * **BISAP Score:** A simple bedside tool for predicting mortality (BUN, Impaired mental status, SIRS, Age > 60, Pleural effusion).

Q: Which of the following statements is FALSE regarding Zollinger-Ellison syndrome?

It may be associated with insulinomas.. **Explanation:** **1. Why Option D is the Correct (False) Statement:** Zollinger-Ellison Syndrome (ZES) is characterized by hypergastrinemia due to a gastrinoma. While ZES is frequently associated with **Multiple Endocrine Neoplasia type 1 (MEN1)**, the classic triad of MEN1 consists of **Parathyroid** hyperplasia, **Pituitary** adenomas, and **Pancreatic** islet cell tumors. Within the MEN1 spectrum, the most common pancreatic neuroendocrine tumor (NET) associated with ZES is the gastrinoma itself. While insulinomas can occur in MEN1, they are not a diagnostic or characteristic feature of ZES. The question asks for the false statement; since ZES is defined by gastrinomas, not insulinomas, Option D is the outlier. **2. Analysis of Incorrect (True) Options:** * **Option A:** True. ZES is caused by a gastrin-secreting neuroendocrine tumor (gastrinoma), typically located in the "Gastrinoma Triangle" (Passaro’s Triangle). * **Option B:** True. In cases where fasting gastrin levels are inconclusive (100–1000 pg/mL), **Secretin stimulation tests** (the most sensitive provocation test) are used. A rise in gastrin >200 pg/mL after secretin injection is diagnostic. * **Option C:** True. Excessive acid production leads to refractory peptic ulcers. While most occur in the first part of the duodenum, ulcers in "unusual" locations like the distal duodenum or jejunum are highly suggestive of ZES. **3. High-Yield Clinical Pearls for NEET-PG:** * **Gastrinoma Triangle Boundaries:** Junction of cystic/common bile duct, junction of 2nd and 3rd parts of the duodenum, and neck/body of the pancreas. * **Most Common Site:** The duodenum is the most common site for gastrinomas in MEN1 patients. * **Clinical Presentation:** Refractory PUD and chronic watery diarrhea (due to lipase inactivation by low pH). * **Diagnosis:** Fasting serum gastrin >1000 pg/mL + Gastric pH < 2.0.

Question 1

A 60-year-old man with a history of heavy alcohol consumption presented with symptoms suggestive of acute pancreatitis that began 4 days ago. He continued to consume alcohol and was admitted for further evaluation. He is currently experiencing severe vomiting and complains of dizziness upon standing. Examination reveals epigastric and right hypochondrium tenderness, with a reddish discoloration noted in the flanks. Which of the following statements regarding the patient is most accurate?

Accepted Answer

Contrast CT scan of the abdomen will reveal severe necrotizing pancreatitis.

Answer

The patient should be evaluated for concomitant appendicitis.

Answer

Ultrasound is likely to demonstrate a pseudocyst of the pancreas.

Answer

Pancreatic calcification will be seen in an X-ray of the abdomen.

Question 2

Which type of pancreatitis generally has a good prognosis?

Accepted Answer

Gallstone pancreatitis

Answer

Postoperative pancreatitis

Answer

Alcoholic pancreatitis

Answer

Chronic pancreatitis

Question 3

What is the most common oncogene involved in pancreatic carcinoma?

Accepted Answer

K-RAS

Answer

P53

Answer

APC

Answer

DCC

Question 4

What is the most common complication after ERCP?

Accepted Answer

Acute pancreatitis

Answer

Acute cholangitis

Answer

Acute cholecystitis

Answer

Duodenal perforation

Question 5

Which of the following is not a complication of a pseudopancreatic cyst?

Accepted Answer

Malignancy

Answer

Rupture

Answer

Hemorrhage into cyst

Answer

Infection

Question 6

Serum amylase level is increased in all of the following conditions except?

Accepted Answer

Acute appendicitis

Answer

Intestinal obstruction

Answer

Perforated ulcer

Answer

Acute pancreatitis

Question 7

A 64-year-old man complains of abdominal pain, pruritus, 4-lb weight loss, and anorexia. There are multiple scratch marks on the skin of the extremities and flank. The bilirubin is 1.0 mg/dL. To determine if the condition is due to cholestasis, blood should be tested for which of the following?

Accepted Answer

Alkaline phosphatase

Answer

Direct and indirect bilirubin

Answer

Serum glutamic-oxaloacetic transaminase (SGOT)

Answer

Serum glutamic-pyruvic transaminase (SGPT)

Question 8

What is the best method for localizing an insulinoma?

Accepted Answer

Endoscopic ultrasonography with intra-operative palpation

Answer

MRI with dynamic CT

Answer

Selective retroperitoneal sonoendoscopy

Answer

Contrast-enhanced computed tomography

Question 9

Which of the following is NOT a criterion for severity in acute pancreatitis?

Accepted Answer

Serum lipase elevated 3-fold

Answer

Serum creatinine > 2.0 mg/dL

Answer

PaO2 < 60 mmHg

Answer

Systolic blood pressure < 90 mmHg

Question 10

Which of the following statements is FALSE regarding Zollinger-Ellison syndrome?

Accepted Answer

It may be associated with insulinomas.

Answer

It is due to the presence of a gastrinoma.

Answer

Gastrin provocation tests are a part of the diagnostic workup.

Answer

It might be associated with ulcers in unusual locations in the gastrointestinal tract.

Pancreatic Surgery — MCQs

Pancreatic Surgery — MCQs

On this page

Practice by Chapter

Want unlimited practice?